Growth Opportunities Imatrex is entering a high growth phase focused on launching a new generation of low-dose CT products for medical applications, signaling a potential trigger for early engagement from imaging hardware suppliers, contract manufacturers, and regulatory consultants.

Imaging Leadership As a leader in advanced imaging solutions for image-guided cancer therapy and non-invasive cardiac imaging, there is a clear pathway to discuss partnerships around product development, validation, and clinical adoption with hospitals, clinics, and research centers.

Technical Stack Proficiency in CAD/CAx (AutoCAD, SOLIDWORKS) and web/content platforms (Joomla, WordPress) coupled with standard enterprise tools (Google Workspace, Microsoft Office) suggests potential for collaboration on device design, documentation, and marketing infrastructure.

Financial Footprint Current revenue range of 1–10 million and a lean employee base (11–50) indicate opportunities for scalable partnerships, pilot programs, and phased deployments with clear ROI metrics to reduce risk for larger buyers.

Market Fit Target markets include low-dose CT for office screening, image-guided cancer therapy, and non-invasive cardiac imaging, presenting cross-sell opportunities with suppliers of radiology equipment, imaging software, and medical device integrators seeking compatible solutions.